Japanese
close

FI (list display)

  • C07K16/00
    		•  Immunoglobulins, e.g. monoclonal or polyclonal antibodies [6] HB CC 4H045
  • C07K16/02
    		•  .from eggs [6] HB CC 4H045
  • C07K16/04
    		•  .from milk [6] HB CC 4H045
  • C07K16/06
    		•  .from serum [6] HB CC 4H045
  • C07K16/08
    		•  .against material from viruses [6] HB CC 4H045
  • C07K16/10
    		•  ..from RNA viruses [6] HB CC 4H045
  • C07K16/12
    		•  .against material from bacteria [6] HB CC 4H045
  • C07K16/14
    		•  .against material from fungi, algae or lichens [6] HB CC 4H045
  • C07K16/16
    		•  .against material from plants [6] HB CC 4H045
  • C07K16/18
    		•  .against material from animals or humans [6] HB CC 4H045
  • C07K16/20
    		•  ..from protozoa [6] HB CC 4H045
  • C07K16/22
    		•  ..against growth factors [6] HB CC 4H045
  • C07K16/24
    		•  ..against cytokines, lymphokines or interferons [6] HB CC 4H045
  • C07K16/26
    		•  ..against hormones [6] HB CC 4H045
  • C07K16/28
    		•  ..against receptors, cell surface antigens or cell surface determinants [6] HB CC 4H045
  • C07K16/30
    		•  ...from tumour cells [6] HB CC 4H045
  • C07K16/32
    		•  ..against translation products from oncogenes [6] HB CC 4H045
  • C07K16/34
    		•  ..against blood group antigens [6] HB CC 4H045
  • C07K16/36
    		•  ..against blood coagulation factors [6] HB CC 4H045
  • C07K16/38
    		•  .against protease inhibitors of peptide structure [6] HB CC 4H045
  • C07K16/40
    		•  .against enzymes [6] HB CC 4H045
  • C07K16/42
    		•  .against immunoglobulins (anti-idiotypic antibodies) [6] HB CC 4H045
  • C07K16/44
    		•  .against material not provided for elsewhere [6] HB CC 4H045
  • C07K16/46
    		•  .Hybrid immunoglobulins (hybrids of an immunoglobulin with a peptide not being an immunoglobulin C07K 19/00) [6] HB CC 4H045
    TOP